TREATMENT PERSISTENCE AMONG TREATMENT-EXPERIENCED PEOPLE WITH HIV (PWH) SWITCHING TO INTEGRASE STRAND TRANSFER INHIBITOR (INSTI)-BASED HIV ANTIRETROVIRAL REGIMENS

被引：0
|
作者：
Chuo, C. Y. [1 ]
Christoph, M. J. [1 ]
Zachry, W. [1 ]
de Boer, M. [1 ]
Chen, M. [1 ]
Trom, C. [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR119
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 50 条
  • [21] ART regimen persistence among treatment-experienced patients with HIV switching to a MTR or STR since 2018
    Chastek, B.
    Anderson, A.
    Webb, N.
    Rock, M.
    Gruber, J.
    Majethia, S.
    Zachry, W.
    Cohen, J.
    Colson, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 102 - 103
  • [22] Cost-Efficacy Comparison among Three Antiretroviral Regimens in HIV- 1 Infected, Treatment-Experienced Patients
    Jörg Ruof
    Alexander Dusek
    Michael DeSpirito
    Ralph A. DeMasi
    Clinical Drug Investigation, 2007, 27 : 469 - 479
  • [23] Cost-efficacy comparison among three antiretroviral regimens in HIV-1 infected, treatment-experienced patients
    Ruof, Joerg
    Dusek, Alexander
    DeSpirito, Michael
    DeMasi, Ralph A.
    CLINICAL DRUG INVESTIGATION, 2007, 27 (07) : 469 - 479
  • [24] Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV - An Alternative Viewpoint
    Gillette, Michael A.
    Shah, Bhavik M.
    Schafer, Jason J.
    DeSimone, Joseph A., Jr.
    PHARMACOTHERAPY, 2014, 34 (09): : A173 - A174
  • [25] Antiretroviral therapy and weight gain in antiretroviral treatment-experienced HIV patients: A review
    Dupont, Emilie
    Cyr Yombi, Jean
    AIDS REVIEWS, 2023, 25 (01) : 54 - 64
  • [26] Darunavir: a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection
    Robertson, Jaime
    Feinberg, Judith
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (09) : 1363 - 1375
  • [27] Risk factors associated with 10% weight change in treatment-naive and treatment-experienced people living with HIV initiating or switching to an NNRTI- or INSTI-based antiretroviral therapy in four large cohort studies
    Robineau, O.
    Marongiu, A.
    Stellbrink, H.
    Meynard, J.
    Brunetta, J.
    Turner, D.
    Monforte, A. D'Arminio
    Castano-Carracedo, M.
    van Welzen, B.
    Williams, L.
    Haubrich, R.
    Heinzkill, M.
    Sahali, S.
    Schreiber, S.
    Gruber, J.
    Cohen, C.
    Esser, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 144 - 146
  • [28] Virological evolution in HIV treatment-experienced patients with raltegravir-based salvage regimens
    Katlama, C.
    Caby, F.
    Andrade, R. M.
    Schneider, L.
    Canestri, A.
    Ktroza, N.
    Tubiana, R.
    Valantin, M. A.
    Wirden, M.
    Mallet, I.
    Calvez, V.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A13 - A13
  • [29] Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV InfectionRationale and Results
    Babafemi Taiwo
    Robert L. Murphy
    Christine Katlama
    Drugs, 2010, 70 : 1629 - 1642
  • [30] OPTIMIZATION OF A POTENT HIV-1 INTEGRASE STRAND TRANSFER INHIBITOR (INSTI): MOLECULAR MODELING, SYNTHESIS AND ANTI-HIV ACTIVITY
    De Grazia, Sara
    Ferro, Stefania
    De Luca, Laura
    Barreca, Maria Letizia
    Debyser, Zeger
    Chimirri, Alba
    DRUGS OF THE FUTURE, 2009, 34 : 140 - 140
12345